Tirzepatides role in targeting adipose tissue macrophages to reduce obesity-related inflammation and improve insulin resistance
Okunogbe, Nugent, Spencer)
Practitioners review questionnaire responses and may request additional medical records or lab results before authorizing prescriptions
Off-label use for low-BMI cosmetic weight loss is not supported by the evidence, exposes the patient to real risks (including rapid muscle loss and rebound after discontinuation), and typically isn't covered by insurance
Patients should prepare for the discussion by documenting their weight trajectory, current eating patterns, exercise routine, and any symptoms or concerns
Therefore, it is inaccurate to state this product has the cheapest verified dose